Screen Failures Are Prospects, Not Dead Ends

The most under-used asset at most sites

Every site has them: people who came in, consented to screening, gave blood, sat through a two-hour visit, and then failed on an exclusion criterion. They walked out the door and, in most site datasets, never came back. That's a shame, because a screen failure is the most qualified prospect you will ever have. They showed up. They understood consent. They tolerated the process. They wanted to participate.

The only thing wrong with them was the protocol.

Record the reason, not just the outcome

Most EDC and CTMS records capture "screen fail" with a checkbox and maybe a free-text note. That's not enough to re-use later. Build a structured screen-failure reason field your coordinators complete before the chart closes, with categories you can actually query:

• Lab value out of range — and which lab, and the value
• Washout or concomitant medication conflict
• Disease severity too high or too low
• Comorbidity exclusion — which one
• Imaging or diagnostic finding
• Logistics — travel, work schedule, caregiver availability
• Withdrew consent during screening

The difference matters enormously. Someone excluded for an A1c of 6.4 when the protocol wanted 7.0 or higher is a strong candidate for a prediabetes study and may qualify for the same indication in eighteen months. Someone excluded for an active malignancy is likely permanently out for that therapeutic area. Treat those two records identically and you waste calls on one and miss the other.

Capture consent to be re-contacted

This is the step that quietly kills most re-engagement programs. If your screening consent doesn't include a future-contact provision, or if you don't have a separate IRB-approved registry consent, you cannot reach back out. Fix it at the source:

1. Add a re-contact opt-in to your site-level recruitment registry consent and offer it to every screening participant, pass or fail.
2. Have the coordinator present it at the end of the screening visit, not the beginning — after rapport exists.
3. Frame it honestly: "This study isn't a fit, but we run studies in this area regularly and I'd like permission to call you when something matches."

Record the opt-in status and the date. Review the language with your IRB before you use it.

Close the loop the same week

Don't let the screen failure be the last contact. Sites that handle this well call the participant within a few days, explain in plain language what disqualified them, and — where appropriate — tell them what to share with their own physician. An out-of-range lab or an incidental imaging finding is genuinely useful health information, and delivering it well is often the reason that person refers a friend later.

Run a quarterly re-match pass

Set a standing calendar block. Pull your screen-failure list, filter by reason category, and cross-reference against protocols in startup and feasibility. Practical filters that tend to produce hits:

• Washout failures where enough time has now passed
• Lab values near a threshold that a new protocol defines more loosely
• Logistics failures where the new study has fewer visits or remote options
• Severity mismatches, since chronic disease progresses

Feed it back into feasibility

Aggregate screen-failure reasons and use them when you review a new protocol. If two-thirds of your failures on the last three studies in an indication came from one exclusion criterion, that's a concrete argument to raise with the sponsor during feasibility — and a realistic basis for the enrollment number you commit to.